SUBJECTS : Basic Science | Clinical Science | Translational | Genetics | Drug Targeting | Biomedicin
EBioMedicine: 2023, vol: 98, issue:
- 1)- Hedwig D Vrijmoeth, Jeanine Ursinus, Margriet G Harms, Anna D Tulen, M E Baarsma, Freek R van de Schoor, Stefanie A Gauw, Tizza P Zomer, Yolande M Vermeeren, José A Ferreira, Hein Sprong, Kristin Kremer, Hans Knoop, Leo A B Joosten, Bart Jan Kullberg, Joppe W Hovius, Cees C van den Wijngaard. Determinants of persistent symptoms after treatment for Lyme borreliosis: a prospective observational cohort study. EBioMedicine. 2023, 98: 104825
Cited : 6Read More - 2)- Xiaotao Zhang, Ehsan Irajizad, Kristi L Hoffman, Johannes F Fahrmann, Fangyu Li, Yongwoo David Seo, Gladys J Browman, Jennifer B Dennison, Jody Vykoukal, Pamela N Luna, Wesley Siu, Ranran Wu, Eunice Murage, Nadim J Ajami, Jennifer L McQuade, Jennifer A Wargo, James P Long, Kim-Anh Do, Johanna W Lampe, Karen M Basen-Engquist, Pablo C Okhuysen, Scott Kopetz, Samir M Hanash, Joseph F Petrosino, Paul Scheet, Carrie R Daniel. Modulating a prebiotic food source influences inflammation and immune-regulating gut microbes and metabolites: insights from the BE GONE trial. EBioMedicine. 2023, 98: 104873Cited : 6Read More
- 3)- Terry M Nolan, Georgia Deliyannis, Maryanne Griffith, Sabine Braat, Lilith F Allen, Jennifer Audsley, Amy W Chung, Marcin Ciula, Nicholas A Gherardin, Michelle L Giles, Tom P Gordon, Samantha L Grimley, Lana Horng, David C Jackson, Jennifer A Juno, Katherine Kedzierska, Stephen J Kent, Sharon R Lewin, Mason Littlejohn, Hayley A McQuilten, Francesca L Mordant, Thi H O Nguyen, Vanessa Pac Soo, Briony Price, Damian F J Purcell, Pradhipa Ramanathan, Samuel J Redmond, Steven Rockman, Zheng Ruan, Jose. Interim results from a phase I randomized, placebo-controlled trial of novel SARS-CoV-2 beta variant receptor-binding domain recombinant protein and mRNA vaccines as a 4th dose booster. EBioMedicine. 2023, 98: 104878Cited : 6Read More
- 4)- Charlotte Keung, Thang Chien Nguyen, Rebecca Lim, Angela Gerstenmaier, William Sievert, Gregory T Moore. Local fistula injection of allogeneic human amnion epithelial cells is safe and well tolerated in patients with refractory complex perianal Crohn's disease: a phase I open label study with long-term follow up. EBioMedicine. 2023, 98: 104879Cited : 3Read More
- 5)- Bo Wang, Chu Tang, En Lin, Xiaohua Jia, Ganyuan Xie, Peiping Li, Decheng Li, Qiyue Yang, Xiaoyong Guo, Caiguang Cao, Xiaojing Shi, Baojia Zou, Chaonong Cai, Jie Tian, Zhenhua Hu, Jian Li. NIR-II fluorescence-guided liver cancer surgery by a small molecular HDAC6 targeting probe. EBioMedicine. 2023, 98: 104880Cited : 2Read More
- 6)- Kai Jia, Steven Kundrot, Matvey B Palchuk, Jeff Warnick, Kathryn Haapala, Irving D Kaplan, Martin Rinard, Limor Appelbaum. A pancreatic cancer risk prediction model (Prism) developed and validated on large-scale US clinical data. EBioMedicine. 2023, 98: 104888Cited : 7Read More
- 7)- Manuel Spitschan, Laura Kervezee, Renske Lok, Elise McGlashan, Raymond P Najjar, . ENLIGHT: A consensus checklist for reporting laboratory-based studies on the non-visual effects of light in humans. EBioMedicine. 2023, 98: 104889Cited : 10Read More
- 8)- Olha Puhach, Mathilde Bellon, Kenneth Adea, Meriem Bekliz, Krisztina Hosszu-Fellous, Pascale Sattonnet, Nicolas Hulo, Laurent Kaiser, Isabella Eckerle, Benjamin Meyer. SARS-CoV-2 convalescence and hybrid immunity elicits mucosal immune responses. EBioMedicine. 2023, 98: 104893Cited : 4Read More
- 9)- Leshan Xiu, Huimin Li, Qinqin Hu, Yuqian Zhang, Shen-Bo Chen, Chenxi Wang, Xiao-Nong Zhou, Jun-Hu Chen, Kun Yin. A versatile microfluidic platform for malaria infection screening and Plasmodium species genotyping. EBioMedicine. 2023, 98: 104898Cited : 2Read More
- 10)- Xuan Xie, Chao Shen, Xiandi Zhang, Guoqing Wu, Bojie Yang, Zengxin Qi, Qisheng Tang, Yuanyuan Wang, Hong Ding, Zhifeng Shi, Jinhua Yu. Rapid intraoperative multi-molecular diagnosis of glioma with ultrasound radio frequency signals and deep learning. EBioMedicine. 2023, 98: 104899Cited : 3Read More
- 11)- eBioMedicine. Therapeutic advances and open questions in postpartum-depression research. EBioMedicine. 2023, 98: 104925Cited : 0Read More
